RIBOMIC
Live / Registered — Registered (as of 08 Dec 2020)
What this means for you
Registered since 08 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79279654
- Registration number
- 6213624
- Mark type
- Design + words
- Filed
- 09 Jul 2019
- Published for opposition
- 22 Sept 2020
- Registered
- 08 Dec 2020
- Attorney of record
- Keith R. Obert
Goods and services
- Class 001 — Chemicals: Chemicals for use in stabilization of RNA before purification and after purification under laboratory experiment and medical examination; chemical reagents for separating, detecting, measuring and analyzing proteins; ribonucleic acid (RNA) for laboratory use; nuclease for scientific or laboratory purposes; unsticking and separating preparations for scientific or laboratory purposes; chemicals for use in industry and science; artificial sweeteners; reagents for medical research
- Class 005 — Pharmaceuticals: Reagents for medical purposes or medical reagents for diagnostic purposes; chemical preparations for pharmaceutical or medical purposes, namely, for treating vision failure, hearing failure, bone growth failure, lung failure, heart failure, articular failure, mental disorders, central nervous system disorder, blood disorders, skin disorders, pain, inflammation, kidney failure, liver failure, fibrosis, metabolic disorders, endocrine diseases, gynecological diseases, respiratory diseases, cardiovascular diseases, tissue regeneration and cancer; tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for preventing and treating infectious diseases; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; reagent paper for medical purposes; gauze for dressings; capsules sold empty for pharmaceuticals; adhesive plasters for medical purposes; dental materials, namely, implants comprising living tissues; dietary supplements for humans
- Class 042 — Scientific and technological services: Testing, inspecting, analyzing, surveying, and research and development relating to pharmaceuticals; testing, inspecting or researching of medical technologies, and providing information and consultancy services relating thereto; research and development of pharmaceuticals and medical supplies; providing information relating to research of pharmaceuticals and medical supplies; testing, inspecting or researching of chemicals for medical use; quality evaluation and analysis of functions of chemical compositions available for medical purposes; providing information on medical researches; DNA analysis services for scientific research purposes; cytogenetic testing for scientific research purposes; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing temporary use of on-line non-downloadable computer programs for drug candidate discovery tools on data networks; designing of machines, apparatus, instruments including their parts or systems composed of such machines, apparatus and instruments; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research in the field of machines, apparatuses and instruments in the field of detection of trace components, hazardous substances and microorganisms
Owner
- RIBOMIC INC., JP
- RIBOMIC INC., JP
- RIBOMIC INC., JP
Prosecution history
- 08 Dec 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 04 Apr 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 11 Mar 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 11 Mar 2021 — FINAL DISPOSITION PROCESSED
- 08 Mar 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 08 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 22 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Sept 2020 — PUBLISHED FOR OPPOSITION
- 18 Sept 2020 — REFUSAL PROCESSED BY IB
- 02 Sept 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Aug 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Aug 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Aug 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Aug 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED